Small Molecule CDMOs

Enteris BioPharma (now MOD3 Pharma, acquired by Aptar Pharma) was a US-based CDMO specializing in the development and manufacture of difficult-to-formulate oral drug products. Operating from a 32,000 sq ft FDA-inspected, cGMP-compliant facility in northern New Jersey, the company offered custom formulation development and clinical trial manufacturing services.

Farmak JSC

Poland

Farmak JSC is the leading pharmaceutical manufacturer in Ukraine, producing medicines for over 60 countries with more than 3,000 employees. The company offers contract manufacturing services for APIs and finished medicinal products in a wide range of dosage forms including liquids, solids, semi-solids, soft gelatin capsules, and sterile injectables, working with European and Ukrainian companies.

Fine Foods & Pharmaceuticals N.T.M. SpA

Italy

Fine Foods & Pharmaceuticals N.T.M. SpA is an Italian integrated CSDMO (Contract Services Development and Manufacturing Organization) serving pharmaceutical, food supplement, cosmetic, medical device, and biocide sectors. With over 100 manufacturing lines and 100 million euros in investments over 5 years, it is one of Italy's leading contract manufacturers with an 11% average annual growth rate.

Fuji Chemical Industries Co., Ltd. is a Japanese pharmaceutical company specializing in API synthesis, spray drying contract manufacturing, drug product manufacturing, and excipient production. Founded in 1946 in Toyama, the company has been an FDA-inspected API manufacturer since 1981, and holds proprietary spray drying technology as well as excipient brands including Neusilin, Fujicalin, and F-melt.

Galenica S.A.

Greece

Galenica S.A. is a Greek pharmaceutical company founded in 1974, operating two EU-GMP certified and FDA-approved manufacturing facilities in Chalkida and Kryoneri. The company offers Contract Manufacturing Operations (CMO) producing injectables, solids, liquids, and semi-liquids for third parties. Galenica also markets its own prescription and OTC medicines and exports to over 18 countries.

GAP S.A.

Greece

GAP S.A. is a Greek pharmaceutical CDMO founded in 1949 with over 70 years of experience, specializing in soft gelatin capsule manufacturing. The company is the largest softgels manufacturer in South Eastern Europe and the sole manufacturer in Greece, serving CDMO partners across Europe, the Middle East, and Asia. GAP also develops and markets its own nutraceutical brand Eviol, the market leader in Greek food supplements.

Gehrlicher GmbH

Germany

Gehrlicher Pharmazeutische Extrakte GmbH is a German family-owned company located in Eurasburg, Bavaria, manufacturing herbal extracts and tinctures since 1964. The company is GMP-certified (since 2010) and offers over 500 herbal formulations, including contract manufacturing of finished medicinal products and bulk supply. Gehrlicher serves pharmaceutical, cosmetics, and food supplement industries with customized extract solutions.

Genetic S.P.A.

Italy

Genetic S.p.A. is an Italian pharmaceutical company dedicated to the research, development, manufacturing, and marketing of therapeutic solutions, including manufacturing on behalf of third parties. The company operates from facilities in Fisciano (Salerno) and Anagni (Frosinone), with liquids and oral solids manufacturing departments. Genetic is present in over 30 European and extra-EU countries and offers third-party manufacturing and out-licensing services.

Guobang Pharmaceutical Group is a global pharmaceutical manufacturing company based in Zhejiang, China, and is among China's top 100 pharmaceutical enterprises. The company specializes in APIs, key pharmaceutical intermediates, and formulations for both human and veterinary health, with products sold to over 115 countries and regions. Founded in 1996, the company employs over 4,000 people across 2,500+ acres of operational land.

Hainan Shuangcheng Pharmaceuticals Co., Ltd. (HNSP) is a publicly-traded Chinese pharmaceutical company founded in 2000, engaged in R&D, manufacturing, and sales of pharmaceutical products with a focus on peptide APIs and injectable formulations. The company offers CDMO/contract manufacturing services representing 20-35% of revenue, and has FDA-registered facilities with multiple FDA inspection history. It operates manufacturing sites in Haikou and has invested in a Ningbo facility.

Hainan Zhonghe Pharmaceutical Co., Ltd., a subsidiary of Hainan Zhonghe (Group) Co., Ltd., is described as a leading high-tech pharmaceutical enterprise in Asia. The company manufactures pharmaceutical products including APIs and finished dosage forms such as Eptifibatide Injection, Entecavir Dispersible Tablets and Capsules, and Octreotide. It sells APIs and formulations through CPHI and other channels.

Halewood Laboratories Pvt. Ltd., established in 1984 in Ahmedabad, India, is a WHO GMP-certified contract manufacturing company specializing in pharmaceutical and food product manufacturing under loan license, third-party license, and private label arrangements. The company manufactures tablets, capsules, ORS products, effervescent tablets, energy drinks, and veterinary products, with exports to over 40 countries.

Huayi Pharmaceutical (Anhui) Co., Ltd. is an EU cGMP-approved Sino-British joint venture CDMO located in Hefei, Eastern China. The company specializes in contract development and manufacturing of high-quality generic pharmaceuticals across various dosage forms, offering integrated services from API production through finished dosage form manufacturing.

Jubilant Biosys Limited

India

Jubilant Biosys is a CRDMO (Contract Research, Development and Manufacturing Organization) under Jubilant Pharmova. Over 20 years experience, 2,400+ employees, five sites across India and Europe. Offers integrated drug discovery (IDD), chemistry services, biology services, and CDMO services including process R&D, analytical development, technology transfer, GLP/non-GMP/GMP manufacturing. Recently expanding into biologics and ADC discovery at European site. FDA registered with 3 FEI numbers, 14 inspections including 4 OAI -- regulatory risk flag. Note: Website claims biologics/ADC capability but this is at discovery stage only, not GMP manufacturing.

KD Pharma Group

Germany

KD Pharma Group is a pure-play, technology-driven CDMO with unique expertise in lipids (omega-3 APIs from fish and algae) and specialized small molecule products. Offers vertically integrated services: API manufacturing (lipid-based and small molecule), finished dosage forms (softgels, liquid bottling, packaging). Pharma division (KD Pharma) provides pharmaceutical APIs and custom synthesis. Nutra division (KD Nutra) serves nutritional supplement companies. KD Biopharma runs Phase 3 clinical trials for lipid-based therapeutics (FAP, UC, COVID-19). Recently expanded manufacturing site in Seal Sands, UK. FDA registered with 2 FEI numbers, 3 inspections (3 VAI).

Laboratorios Farmaceuticos ROVI S.A. is a major Spanish CDMO and pharmaceutical company, one of the leading European contract manufacturers for high-value-added injectable products. Their CDMO division (ROIS) operates three industrial complexes: two for injectables (Madrid and San Sebastian de los Reyes) and one for oral solid forms and packaging (Alcala de Henares). They also have two facilities in Granada for their own products (bemiparin and enoxaparin). ROVI's Madrid injectables plant is approved by EMA, FDA, and regulators in Korea, Brazil, and Gulf States, with ISO 9001, ISO 14001, and OSHAS certifications. They recently acquired a Bristol-Myers Squibb injectable drug product manufacturing site in Phoenix, Arizona for $250 million, expanding their capacity. ROVI provides end-to-end services from development to final product release, including clinical trials, stability studies, and analytical services. They have collaborated with Roche for manufacturing new medicines in development.

PiSA (Grupo PiSA / PiSA Farmaceutica) is a major Mexican pharmaceutical company manufacturing 1,500+ branded medications across 17 specialty lines in 14 production plants strategically located in Mexico. Employs approximately 30,000 workers. PiSA USA serves as the nearshore contract manufacturing arm, offering pharmaceutical and medical device CMO services. Company is a Socially Responsible Enterprise (ESR) for 15 consecutive years. Offers 'Maquila de Productos' (contract manufacturing) as a core service.

Laxai

India

LAXAI Life Sciences is an Indian small molecule CRDMO (Contract Research, Development and Manufacturing Organization) headquartered in Hyderabad. Offers end-to-end services spanning discovery (medicinal chemistry, synthetic chemistry, in-vitro/in-vivo biology, DMPK, safety assessment), development (chemical process development, drug product development, analytical development including method development and validation, impurity profiling, forced degradation studies), and manufacturing (preclinical to FIH supplies, late-phase and commercial, tech transfer, process validation, API manufacturing). Also manufactures specialty chemicals. Recently received investment from SIGNET Healthcare Partners. Passed USFDA audit in March 2025 with zero 483 observations.

Macleods Pharmaceuticals Ltd

India

Macleods Pharmaceuticals Ltd is one of India's top 10 pharmaceutical companies, operating as a CDMO for developing, manufacturing, and globally distributing pharmaceutical products. They produce diverse dosage forms including solid orals, liquid orals, topical formulations, injectables, metered dose inhalers, and dry powder inhalers across therapeutic areas including anti-TB, antimalarials, antiretrovirals, antidiabetics, antihypertensives, and antiasthmatics. They have 152 FDA-approved products, WHO prequalified medicines, and manufacturing facilities compliant with UK MHRA, US FDA, TGA, and WHO guidelines. They operate in 100+ countries.

Nanoform Finland Oyj

Finland

Finnish CDMO specializing in proprietary nanoparticle engineering technology to improve drug bioavailability, enable higher drug loading, and unlock alternative delivery routes (subcutaneous, inhaled). Services span from early development through commercial GMP supply for both small molecules and biologics/peptides. Publicly listed (Nanoform Finland Oyj). Focuses on solving formulation challenges for poorly soluble compounds and enabling patient-centric dosage forms.

Naveh Pharma Ltd.

Israel

Israeli pharmaceutical CDMO providing contract development and manufacturing services for solid oral dosage forms, oral liquids, and semi-solid/topical products. Offers formulation development through commercial manufacturing.

Nectar Lifesciences Ltd.

India

Indian pharmaceutical company with vertically integrated API and formulation manufacturing. FDA registered with 2 FEI numbers (operations: ANALYSIS, API, FDF). Offers CDMO services alongside own branded products. Manufactures both APIs (including beta-lactam antibiotics) and finished dosage forms across oral solids, injectables, and lyophilized products.

NovaCina is a sterile injectable CDMO based in Perth, Western Australia, launched by Bridgewest Group. The company manufactures sterile injectable drug products for all phases from development through commercial production. NovaCina has expanded its facility with a high-tech SA25 GMP filling line for small-batch sizes and has since merged with BioCina to create an end-to-end CDMO offering integrated biopharmaceutical and small molecule contract manufacturing services.

OLIC (Thailand) Limited is one of the largest toll and contract manufacturers in Southeast Asia for branded pharmaceutical and healthcare products. The company is a subsidiary of Fuji Pharma and serves over 30 multinational companies including most Big Pharma organizations. OLIC's PIC/S-compliant manufacturing facility produces a wide range of dosage forms including sterile liquids, oral solids, semi-solids, and liquids, serving markets in Thailand, Southeast Asia, Japan, Australia, the US, and Europe.

Olive HealthCare is a fully-integrated Indian pharmaceutical company specializing in the development, manufacturing, and marketing of soft gelatin capsule formulations for pharmaceutical, OTC, and dietary supplement products. Operating three state-of-the-art manufacturing units in India, the company provides CDMO services including toll manufacturing and full development for global partners.

Oman Pharmaceutical Products Co. LLC is a pharmaceutical manufacturer based in Salalah, Oman, engaged in inhouse formulation manufacturing, out-licensing, and CDMO business. The company produces oral solid dosage forms including tablets and offers contract manufacturing services to partners in the region and beyond.

PHIL Inter Pharma is a CMO/CDMO operating two manufacturing sites in the same industrial park in Vietnam. The company is a soft capsule manufacturer offering CMO/CDMO services from a UK MHRA GMP-accredited facility for pharmaceuticals. PHIL Inter Pharma has 250-499 employees and also manufactures generics/biosimilars. Products include the KOSENA and CALEDO brands. The company has South Korean origins (KR) and a US presence (PHIL Inter Pharma USA). No website data was available for detailed analysis.

PHT International is a full-service Contract Research, Development, and Manufacturing Organization (CRDMO) headquartered in China, providing innovative solutions to leading life science companies. Offers global solutions in contract research and manufacturing to partners within the pharmaceutical, agrochemical, and specialty chemical industries. Includes import/export services and sterile CDMO manufacturing capabilities.

Pii (Pharmaceutics International, Inc.), acquired by Jabil in February 2025, is a US-based CDMO specializing in complex formulations. With over 30 years of experience and 300+ scientists and support staff, Pii handles potent compounds, complex formulations, aseptic injectables, complex oral dosage forms, and high-potency soft gels. Offers phase-appropriate support from early development through commercial manufacturing. Located in Hunt Valley, Maryland. 100% FDA licensed with 5 drug product approvals in 2023.

Reig Jofre (Laboratorio Reig Jofre, S.A.) is a Spanish pharmaceutical company founded in 1929 that operates both as a pharmaceutical company with its own products and as a CDMO. They have four development and production centres in Europe (two in Toledo, one in Barcelona, one in Sweden) with over 1,100 employees. Their CDMO capabilities include sterile lyophilizates, sterile liquids, non-sterile liquids, and beta-lactam manufacturing. Known for excellence in freeze-drying technology and advanced sterile manufacturing. FDA-registered with manufacturing and analysis operations, though regulatory history shows 3 OAI inspections.

Ropack Pharma Solutions is a privately held CMO/CDMO based in Montreal, Canada, specializing in solid oral dose contract manufacturing and comprehensive packaging services. With nearly 50 years of experience, the company provides drug development, tech transfer, clinical and commercial manufacturing, and serialized packaging services for solid oral dosage forms.

Savi Pharmaceutical Joint Stock Company (Savipharm J.S.C, SVP) is a Vietnamese pharmaceutical company founded in 2005 in Ho Chi Minh City. The company operates an oral solid dose factory and provides contract manufacturing of dosage form drugs, franchising, and technology transfer services.

Shree Venkatesh International Limited (SVIL) is an Indian manufacturer and exporter of male and female human hormonal products, including both APIs and finished dosage forms. The company offers contract manufacturing services for pharmaceutical drug products and APIs, with a focus on hormonal therapies. SVIL markets its products internationally through branded and generic channels.

SK Pharmteco is a leading global CDMO providing drug development and manufacturing services across small molecules, gene therapy, and analytical testing. The company operates cGMP facilities in the United States (240-acre California headquarters in Rancho Cordova, King of Prussia PA), Ireland (Dublin - 60+ years of API production), South Korea, and France. They offer custom API manufacturing including HPAPIs, viral vector manufacturing (lentivirus via LentiSure and AAV via AAVelocity platforms, 230+ batches manufactured, 100+ supporting clinical trials), plasmid DNA manufacturing, and analytical services. Recently invested in expanding peptide development capabilities and opened a new HPAPI testing lab.

Sovereign Pharmaceuticals, LLC is a U.S.-based CDMO located in Fort Worth, Texas, specializing in small-batch prescription drugs. The company packages both solid and liquid pharmaceutical products and has a high potency pharma suite. Sovereign has over 30 years of expertise and was acquired through bankruptcy proceedings by Alora Pharmaceuticals.

Stelis Biopharma is a leading, fully integrated biopharmaceutical CDMO based in India (Bangalore) with over 30 years of operational excellence. They brand themselves as 'OneSource' -- a multimodal specialty pharma CDMO with end-to-end capabilities across multiple tech platforms and therapeutic modalities. Their capabilities span biologics (microbial and mammalian cell culture, drug substance and drug product), complex sterile injectables (35 approved ANDAs and 19 commercialized drug products in the US), drug-device combinations (20+ automatic/semi-automatic assembly stations for prefilled syringes, pen injectors, autoinjectors), and soft gelatin capsules (2.4 billion per year capacity). They operate 5 state-of-the-art facilities approved by various regulatory bodies. Syngene acquired Stelis Biopharma's Unit 3 plant in Bangalore for biologics manufacturing.

Tirupati Group is one of India's largest contract development and manufacturing organizations (CDMOs), providing end-to-end solutions across pharmaceuticals, nutraceuticals, Ayurveda, and sports nutrition. Founded in 2005, the company operates state-of-the-art manufacturing facilities in Paonta Sahib (Himachal Pradesh) and Noida (Uttar Pradesh), serving 350+ clients including Abbott, Pfizer, Dr. Reddy's, and Sun Pharma.

Zhejiang Langhua Pharmaceutical Co., Ltd. is a comprehensive CDMO subsidiary of Viva Biotech Holdings, specializing in small molecule contract development and manufacturing. Viva Biotech acquired Langhua for RMB 2,560 million ($368M) to build out their CDMO service chain capabilities. Langhua offers CMC development, API synthesis, and formulation services from pre-clinical through commercial scale. They have completed numerous CDMO cases and have a subsidiary Ningbo Nuobai Pharmaceutical for additional capacity. The company is FDA-registered (FEI 3005289386) and has passed an FDA on-site cGMP inspection, with 3 total FDA inspections (1 NAI, 2 VAI, 0 OAI). They market themselves explicitly as a CDMO offering end-to-end services from CMC through API to formulation manufacturing. No website text was available (empty), so classification relies on search results and regulatory data.

E-Pharma Trento S.p.A. is an Italian CDMO specialized in solid oral dosage forms, offering a high level of outsourcing from drug development to private label manufacturing. The company is known for its sublingual technology and serves pharmaceutical companies with contract development and manufacturing services.

Genuone Sciences Inc. is a South Korean pharmaceutical CDMO valued at approximately $752 million, offering specialized contract development and manufacturing services including formulation development through finished product production. The company provides pharmaceutical manufacturing and analytical services for both domestic and international clients. Genuone is 100% owned by IMM Private Equity.

J‑STAR Research, Inc.

United States

J-STAR Research is a contract process R&D and cGMP manufacturing organization (subsidiary of Porton Pharma Solutions) serving the pharmaceutical and biotech industry. Founded 1996, focused on small molecule drug substance and drug product development. Offers process chemistry R&D, crystallization R&D, high potent compound handling, controlled substances, analytical R&D, QC, and drug product formulation. Two NJ-based R&D centers totaling 129,000 SF. FDA registered with API MANUFACTURE operations.

Lachifarma is an Italian CMO/CDMO based in Zollino (Lecce), Italy, offering research, technological development, and pharmaceutical contract manufacturing services. Listed as an EU GMP CMO, it appears in European CDMO landscape analyses alongside companies like Fine Foods, Doppel, and Biofarma. Lachifarma has been involved in vaccine-related contract manufacturing and offers pharmaceutical dose manufacturing services.

Lyomark Pharma GmbH

Germany

Lyomark Pharma GmbH is a German CDMO specializing in sterile medicinal products. They organize contract manufacturing based on dossiers they compile and maintain, and offer regulatory services. Through their subsidiary Lyocontract, they operate a state-of-the-art pharmaceutical manufacturing site. They have 39 FDA-approved products across injectable, oral solid, and liquid dosage forms. The company focuses on niche indications for the hospital market with global distribution.

Morgen Pharmaceutical Services (MPhS), operating as Stason Pharmaceuticals, is a US-based CDMO offering end-to-end drug development and manufacturing services. Located in Irvine, California, the facility can produce over 2 billion oral doses per year with batch sizes from 0.5 kg to 600 kg. The company offers API synthesis (through offshore affiliates), formulation development, pre-formulation studies, solid dosage manufacturing (tablets and capsules), high-containment operations for highly potent compounds (OEL < 1 µg/m³), and injectable/liquid manufacturing through a partner facility in Tainan, Taiwan. FDA-registered with 2 FEI numbers and 11 FDA inspections (8 NAI, 3 VAI).

Indian pharmaceutical CDMO specializing in pre-finished formulation intermediates (PFI) and finished dosage forms (FDF). Manufactures oral solids, oral liquids, injectables, ophthalmics, topicals, and inhalation products. Strong focus on pellet technology and nanotechnology-based drug delivery systems. CRAMS (Contract Research and Manufacturing Services) provider.

Nanjing Sino Pharmaceutical Ltd.

China

Chinese pharmaceutical company specializing in production, R&D, and export of generic medicines globally. Covers 1,000+ products across antibiotic, antimalarial, analgesic-antipyretic, cardiovascular, respiratory, antiviral/anti-cancer, hormone, and other therapeutic categories. 20+ years of international registration and export experience in dozens of countries. FDA registered with 3 FEI numbers.

NEON LABORATORIES LTD

India

Indian pharmaceutical company (established 1984) that emerged as a leader in anesthesia and critical care products. Manufactures 500+ products sold in 70+ markets. Multi-located manufacturing facilities including API and formulations. Started as contract manufacturer for anesthesia products (1992) and grew into branded generics. Major plant at Palghar with 460 million units capacity. Has dedicated manufacturing units for cephalosporins and oncology to avoid cross-contamination. 2000+ employees. FDA registered with 3 FEI numbers, 29 inspections (13 NAI, 15 VAI, 1 OAI). Began API production in 2008. Also has medical devices division (HOSPRO).